Gregory Bolan’s experience as a research analyst is very strong, which is why he is a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services at Avondale Partners, LLC, a boutique investment banking and asset management firm. Before beginning his time at Avondale Partners, Gregory served as the Managing Director of Healthcare Equity Research with Sterne Agee, in their Nashville office, where he focused primarily on pharmaceutical companies. In 2014, he was recognized as a No. 1 Stock Picker for Life Science Tools & Services by Starmine and, in 2010, he was called the “Best Up & Comer” as part of Institutional Investor’s All-American Research Team Survey. Gregory also played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
Gregory Bolan’s financial services career has largely been focused on the healthcare and targeted middle market sectors. He has spent extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company, also in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital in New York City. The primary focus at all of these firms was on the healthcare industry, mostly the buy side.
Gregory also has a lot of valuable education. After four years in the United States Army, where he was an Infantry Rifleman and Squad Leader, Gregory Bolan went on to earn a Bachelor of Business Administration with a major in Finance from the Goizueta Business School at Emory University.